✨PUBLISHED✨ Our scientific statement State of the Art of #ArtificialIntelligence in Clinical #Electrophysiology in 2025 We hope this new checklist helps both researchers & readers alike! Thank you @EmmaSvennberg & @DavidDuncker for the opportunity to contribute 🙏🏼 #EHRA2025

Tell me you don’t regularly take care of patients without saying a word. Clearly this question writer spends more time w a keyboard than a stethoscope 👇🏻 A) what do you use for sedation w/ those hemodynamics and b) how many seconds will this pt stay in SR? H/t @jasonryanmd

I don’t think any woman goes through their training not wanting to work. Over 50% of those who responded did a fellowship. There is a problem with our health system that needs to be resolved to keep the women and men we train in medicine. Including reducing the stress of the job, often due to mistreatment, discrimination & lack of opportunities for leadership roles, in addition to inequity in pay that has long been established.

A mentor can make an exceptional impact on the future of the electrophysiology field by arming the next generation with the skills, tools, and confidence necessary to innovate. Show your appreciation for the mentor who supported you early in your career by donating to HRS through the Honor Your Mentor program. If you choose, we’ll let your mentor know of the gift you made in their name. Make Your Gift ➡️ bit.ly/4dxKvKF

"She has been instrumental to my training, a sounding board for all questions related to work and life challenges, and is a true role model to all." — Heather Wheat, MD, honoring @KTamirisaMD through the HRS Honor Your Mentor program. Who was your mentor? Make a tribute gift today: bit.ly/49x3HGU

Hear from #HRS2026 #SciComms correspondent @veramasloo as she interviews @jongichun about late-breaking clinical trial "A Prospective Randomized Multicenter Global Study Comparing Pulsed Field Ablation versus Anti-Arrhythmic Drug Therapy as a First Line Treatment for Persistent AFib" (AVANT GUARD). Learn more about the LBCTs here: bit.ly/4efh0PE

Only 15 days remain to register for the inaugural CSANZ–HRS PCSCPS Summit in Melbourne this May. Join us for this landmark meeting in pacing & conduction system pacing. Register now → tcc.eventsair.com/pcspsummit @PrashSanders @thecsanz #Cardios #Pacing #ConductionSystemPacing #EPeeps

Heart Rhythm TV is signing off from Chicago! This photo says it all. It's been an honor bringing you every moment. We have SO much content still on the way that we cannot wait for you to see. Stay tuned, and follow Heart Rhythm TV for more ➡️ bit.ly/4cDyK6d The best is yet to come. 🙌 @HRSonline @DanielAlyeshmer, @MehakDhande, @drsuneet, @jczerpa, Jeanne du Fay de Lavallaz, @HeartRhythmNP, @Nashwa_Salem_, @np_varghese, @OliverMonfredi, @AZ_EP_DOC, @melchami99

And just like that — #HRS2026 is officially a wrap! 🎬 For our final wrap up of the week, we're reflecting on an incredible HRS Gala, the energy of the President's Social, and the late-breaking science that kept us on the edge of our seats through the very last session. See the full discussion here #EPeeps ➡️ bit.ly/48jJrIw Four days of connection, discovery, and moments we won't forget. We hope everyone walked away inspired, energized, and ready for what's next — because we sure did. Until next year — see you in San Francisco for #HRS2027! 🌁✨

An unforgettable evening. A powerful impact. The 2026 Heart Rhythm Gala brought together more than 850 members of the global EP community and raised over $875,000 to support the missions for the Heart Rhythm Society and @HeartRhythmAdvo. At the heart of the evening were the voices of patients and clinicians, captured in our “Why We Gather” video, reminding us of the purpose behind our work and the impact we can make together. Explore highlights from the evening and learn more: 🔗 lnkd.in/gzDFx3GN #HRS #HeartRhythmGala #Electrophysiology #Cardiology #Advocacy #EPeeps @SanaAlkhatib9 @PassmanRod @VivekReddyMD @KTamirisaMD

#EHRAroundTheGlobe is at #HRS2026 in Chicago 🇺🇸 We sat down with @SergeBoveda to deep dive into the most anticipated late-breaking clinical trials from #HRS2026 The science that shapes how we treat our patients 👇

Safety. Quality. Physician Alignment. 🏥 The shift of EP procedures to Ambulatory Surgery Centers is accelerating — but what does it really take to get it right? #HRStv host @MehakDhande sits down with @DrJMarine and @DrRoderickTung to unpack the evolving ASC landscape in EP. See the full interview here #EPeeps ➡️ bit.ly/4mRXbjG

Snagged my 2nd beautiful piece of art (featured on Braunwald’s Heart Disease textbook) donated by @CMichaelGibson at the #HRS2026 Gala last night. Got my 1st piece at last year’s Gala! @HRSonline

Congrats to @omwazni and coinvestigators for this amazing achievement @CleClinicHVTI

#LBCT on #HRS2026! FULCRUM-VT trial:Ultra-low temperature VT ablation by @atulverma_md 🌎209 pts, 19 sites,2/3 ICM,1/3NICM 🧷safety endpoint:2.4% 🎯acute effectiveness 98% ✅chronic effectiveness:59%freedom from VT/AAD escalation, no difference ICMvs NICM ⬇️of VT burden,VTshocks

‼️#HRS26 are we strict enough?

#LBCT #HRS2026 @HRSonline Early US experience of VT ablation with Sphere-9 @Osama_Dasa @Dr_Santangeli 👨‍🦱59pts (VT n=50,PVC n=9) 🎯RFA first line,PFA adjunctive in dense scar, epi-PFA only, no PFA in border zone ✅VT-non ind. 78%; VT free at 6 mo 70% ❗️complications 5%

📢LBCT #HRS2026 ( Simultaneous pub @hrs_journal ) *⃣ Proton Beam Cardiac Radioablation for VT @MayoClinicCV #SciComms *⃣ Catheter-free proton beam radioablation (CRA) for refractory VT ➡️First-in-human feasibility study (n=7 treated) • Advanced cardiomyopathy (median LVEF ~26%) • Refractory VT despite AADs prior ablation • Single fraction 30 Gy proton therapy 🎯 Key concept: Protons enable highly conformal targeting (Bragg peak) with minimal exit dose ➡️Efficacy signal: • VT burden ↓ 79% • Event rate: 7.24 → 1.52 events/patient-month 👉 Substantial but incomplete (recurrence in most pts) ➡️Safety: • No probable/definite treatment-related SAEs • No acute ICD dysfunction or peri-procedural complications • Limited off-target radiation (~4% myocardium ≥20 Gy) ➡️ Mechanistic insight: • Effect may be delayed (weeks–months) • May reflect fibrosis EP remodeling, not immediate ablation 🤔Context: • Very high-risk population (HF-driven mortality) • Small, single-arm feasibility study • No control group; targeting remains non-standardized • Long-term toxicity unknown 🧑‍🎓Takeaway: Proton CRA is a feasible, noninvasive VT strategy with encouraging early safety and meaningful VT reduction …but remains early-stage and hypothesis-generating heartrhythmjournal.com/artic…

Good Morning, HRS! ☀️ It’s hard to believe today is the last day of #HRS2026. Hear from @np_varghese and @DJ_Lakkireddy about the highlights of this incredible event, what to expect today, an a glimpse into #HRS2027 in San Francisco!

Absolutely PACKED @HRSonline LBCT session on VT ablation in S100C! Great science being presented - see below outstanding reporting from @veramasloo! ⬇️ #HRS2026

#LBCT on #HRS2026 @HRSonline by Saurabh Kumar CAAD-VT Trial: ablation vs AAD in ICM&NICM 🌎Multicenter,randomized,9centers in Australia 🔚endpoint: free from VT, VT storm,death 👨‍🦱100pts,48%ICM,52%NICM on FU 36mo, ablation: REDUCED RISK OF COMPOSITE ENDPOINT vs AAD (51%vs71%)